Design Therapeutics, Inc. (DSGN) has a market capitalization of $779.54M and trades at $12.64. The 52-week range is 2.6-11.299.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -10.4, Earnings Per Share (EPS) of $-1.22.
The stock has a beta of 1.58, operates in the Healthcare sector.
